Gut

Gut is a peer-reviewed medical journal on gastroenterology and hepatology. It is the journal of the British Society of Gastroenterology and is published by the BMJ Group, which is a subsidiary of the British Medical Association. Gut has been published since 1960 and focuses on articles and original research about the gastrointestinal tract, liver, pancreas, and biliary tract. The journal is published monthly, with annual supplements covering the presentations from the British Society of Gastroenterology Annual General Meeting. British Society of Gastroenterology clinical practice guidelines are also published as supplements to the journal. As of March 2010 subscribers to Gut also receive a copy of Frontline Gastroenterology, which is also co-owned by the British Society of Gastroenterology. Gut is available online by subscription and archived editions of the journal (older than one year) are available free of charge. It is edited by Emad El-Omar, who was appointed in 2010. Gut is indexed by Medline, Science Citation Index, Current Contents/Clinical Medicine, Current Contents/Life Sciences, Excerpta Medica, and BIOSIS Previews. According to the Journal Citation Reports, its 2009

Publisher
BMJ Group
Country
United Kingdom
History
1960–present
Impact factor
10.614 impact-year ()

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Antibiotic use linked to heightened bowel cancer risk

Antibiotic use (pills/capsules) is linked to a heightened risk of bowel (colon) cancer, but a lower risk of rectal cancer, and depends, to some extent, on the type and class of drug prescribed, suggests research published ...

Surgery

Will disposable colonoscopy devices replace reusables?

As a disposable version of the instrument used in one of the most common medical procedures in the United States inches closer to widespread availability, a team of Johns Hopkins data researchers is studying the economic ...

Oncology & Cancer

Researchers find new method to halt the advance of liver cancer

A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the ...

page 1 from 11